Background. Allograft rejection remains a major cause of morbidity and mortality after lung transplantation and is associated with increased gene expression for proinflammatory cytokines. T cells are a major cell type involved in graft rejection. There have been no previous studies of cytokine production by T cells from blood, bronchoalveolar lavage (BAL), and intraepithelial T cells from bronchial brushings (BB) during rejection episodes; we hypothesized that T-cell proinflammatory cytokines would be increased in the airways during rejection episodes despite standard immunosuppression regimens
ACUTE REJECTION (AR) of the graft is still an important clinical problem in lung transplanted patien...
Lung transplantation is the definitive treatment for terminal respiratory disease, but the associate...
BACKGROUND: Cytokines are important mediators of the complex process of extravasation and influx of ...
Background. Allograft rejection remains a major cause of morbidity and mortality after lung transpla...
Allograft rejection remains a major cause of morbidity and mortality following lung transplantation ...
The definitive version is available at www.blackwell-synergy.comCurrent immunosuppression protocols ...
P>Immunosuppression therapy following lung transplant fails to prevent chronic rejection/bronchiolit...
Acute lung rejection (ALR) is a relatively frequent complication during the first year after lung tr...
BackgroundBronchiolitis obliterans syndrome (BOS) is the single most important factor that limits lo...
Early diagnosis and treatment of acute cellular rejection (ACR) may improve long-term outcome for lu...
Allograft rejection remains a major cause of morbidity and mortality following lung transplantation ...
Acute rejection (AR) is an important complication that can occur after lung transplantation and cons...
BACKGROUND uman lung transplantation has evolved to an established treatment for pulmonary diseases...
The role of differential cytology patterns in peripheral blood and bronchoalveolar lavage samples is...
Inflammatory injuries directed toward airway structures play a key role in lung allograft rejection....
ACUTE REJECTION (AR) of the graft is still an important clinical problem in lung transplanted patien...
Lung transplantation is the definitive treatment for terminal respiratory disease, but the associate...
BACKGROUND: Cytokines are important mediators of the complex process of extravasation and influx of ...
Background. Allograft rejection remains a major cause of morbidity and mortality after lung transpla...
Allograft rejection remains a major cause of morbidity and mortality following lung transplantation ...
The definitive version is available at www.blackwell-synergy.comCurrent immunosuppression protocols ...
P>Immunosuppression therapy following lung transplant fails to prevent chronic rejection/bronchiolit...
Acute lung rejection (ALR) is a relatively frequent complication during the first year after lung tr...
BackgroundBronchiolitis obliterans syndrome (BOS) is the single most important factor that limits lo...
Early diagnosis and treatment of acute cellular rejection (ACR) may improve long-term outcome for lu...
Allograft rejection remains a major cause of morbidity and mortality following lung transplantation ...
Acute rejection (AR) is an important complication that can occur after lung transplantation and cons...
BACKGROUND uman lung transplantation has evolved to an established treatment for pulmonary diseases...
The role of differential cytology patterns in peripheral blood and bronchoalveolar lavage samples is...
Inflammatory injuries directed toward airway structures play a key role in lung allograft rejection....
ACUTE REJECTION (AR) of the graft is still an important clinical problem in lung transplanted patien...
Lung transplantation is the definitive treatment for terminal respiratory disease, but the associate...
BACKGROUND: Cytokines are important mediators of the complex process of extravasation and influx of ...